InvestorsHub Logo
Followers 0
Posts 826
Boards Moderated 0
Alias Born 04/22/2010

Re: Brad S post# 1132

Sunday, 09/12/2010 12:27:36 AM

Sunday, September 12, 2010 12:27:36 AM

Post# of 60743
Brad, I am pasting the description of SOBM. Key here is 10 Products approved or in development. Remember the company was very good until 2008. Now they are restructuring. I don't see why they should not trade at the level they were trading in 2008. IMO we are going to see lot of developments soon.

Headquartered in Shanghai , China , Sinobiomed Inc. is a leading developer of genetically engineered recombinant protein drugs and vaccines. The company has 10 products approved or in development. Sinobiomed Inc. products are for the treatment of a broad range of diseases and conditions, such as malaria, hepatitis, surgical bleeding, cancer, rheumatoid arthritis, diabetic ulcers, burns, and blood cell regeneration.

The company's research team has strong partnerships with leading Chinese research hospitals and institutes. These are for collaborative development of patented and patentable techniques and treatments. They include associations with the Second Military Medical University (SMMU), and their affiliate hospital, Changhai Hospital . The company also has an alliance with Fudan University.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LGIQ News